Literature DB >> 32786371

[68Ga]Ga-THP-Pam: A Bisphosphonate PET Tracer with Facile Radiolabeling and Broad Calcium Mineral Affinity.

George P Keeling1, Billie Sherin1, Jana Kim1, Belinda San Juan1, Tilmann Grus2, Thomas R Eykyn1, Frank Rösch2, Gareth E Smith3, Philip J Blower1, Samantha Y A Terry1, Rafael T M de Rosales1.   

Abstract

Calcium minerals such as hydroxyapatite (HAp) can be detected noninvasively in vivo using nuclear imaging agents such as [18F]NaF (available from cyclotrons), for positron emission tomography (PET) and 99mTc-radiolabeled bisphosphonates (BP; available from 99mTc generators for single photon emission computed tomography (SPECT) or scintigraphy). These two types of imaging agents allow detection of bone metastases (based on the presence of HAp) and vascular calcification lesions (that contain HAp and other calcium minerals). With the aim of developing a cyclotron-independent PET radiotracer for these lesions, with broad calcium mineral affinity and simple one-step radiolabeling, we developed [68Ga]Ga-THP-Pam. Radiolabeling with 68Ga is achieved using a mild single-step kit (5 min, room temperature, pH 7) to high radiochemical yield and purity (>95%). NMR studies demonstrate that Ga binds via the THP chelator, leaving the BP free to bind to its biological target. [68Ga]Ga-THP-Pam shows high stability in human serum. The calcium mineral binding of [68Ga]Ga-THP-Pam was compared in vitro to two other 68Ga-BPs which have been successfully evaluated in humans, [68Ga]Ga-NO2APBP and [68Ga]Ga-BPAMD, as well as [18F]NaF. Interestingly, we found that all 68Ga-BPs have a high affinity for a broad range of calcium minerals implicated in vascular calcification disease, while [18F]NaF is selective for HAp. Using healthy young mice as a model of metabolically active growing calcium mineral in vivo, we compared the pharmacokinetics and biodistribution of [68Ga]Ga-THP-Pam with [18F]NaF as well as [68Ga]NO2APBP. These studies revealed that [68Ga]Ga-THP-Pam has high in vivo affinity for bone tissue (high bone/muscle and bone/blood ratios) and fast blood clearance (t1/2 < 10 min) comparable to both [68Ga]NO2APBP and [18F]NaF. Overall, [68Ga]Ga-THP-Pam shows high potential for clinical translation as a cyclotron-independent calcium mineral PET radiotracer, with simple and efficient radiochemistry that can be easily implemented in any radiopharmacy.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32786371      PMCID: PMC7611355          DOI: 10.1021/acs.bioconjchem.0c00401

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  66 in total

Review 1.  Molecular mechanisms of bone 18F-NaF deposition.

Authors:  Johannes Czernin; Nagichettiar Satyamurthy; Christiaan Schiepers
Journal:  J Nucl Med       Date:  2010-11-15       Impact factor: 10.057

Review 2.  Normal bone anatomy and physiology.

Authors:  Bart Clarke
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

3.  (18)F-NaF PET/CT: EANM procedure guidelines for bone imaging.

Authors:  M Beheshti; F M Mottaghy; F Paycha; F F F Behrendt; T Van den Wyngaert; I Fogelman; K Strobel; M Celli; S Fanti; F Giammarile; B Krause; W Langsteger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-23       Impact factor: 9.236

4.  68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.

Authors:  Matthias Eder; Martin Schäfer; Ulrike Bauder-Wüst; William-Edmund Hull; Carmen Wängler; Walter Mier; Uwe Haberkorn; Michael Eisenhut
Journal:  Bioconjug Chem       Date:  2012-03-13       Impact factor: 4.774

5.  A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases.

Authors:  Ismaheel O Lawal; Kgomotso M G Mokoala; Johncy Mahapane; Janke Kleyhans; Marian Meckel; Mariza Vorster; Thomas Ebenhan; Frank Rösch; Mike M Sathekge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-18       Impact factor: 9.236

6.  A new complex of 99mTc for skeletal imaging.

Authors:  G Subramanian; J G McAfee
Journal:  Radiology       Date:  1971-04       Impact factor: 11.105

7.  Biodistribution of anionic separated MDP complexes from different MDP preparations.

Authors:  A Handeland; M W Lindegaard; D E Heggli
Journal:  Eur J Nucl Med       Date:  1989

8.  Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of 68Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer.

Authors:  Michael S Hofman; Peter Eu; Price Jackson; Emily Hong; David Binns; Amir Iravani; Declan Murphy; Catherine Mitchell; Shankar Siva; Rodney J Hicks; Jennifer D Young; Philip J Blower; Gregory E Mullen
Journal:  J Nucl Med       Date:  2017-10-06       Impact factor: 10.057

9.  Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography.

Authors:  Agnese Irkle; Alex T Vesey; David Y Lewis; Jeremy N Skepper; Joseph L E Bird; Marc R Dweck; Francis R Joshi; Ferdia A Gallagher; Elizabeth A Warburton; Martin R Bennett; Kevin M Brindle; David E Newby; James H Rudd; Anthony P Davenport
Journal:  Nat Commun       Date:  2015-07-07       Impact factor: 14.919

10.  New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.).

Authors:  Michelle T Ma; Carleen Cullinane; Cinzia Imberti; Julia Baguña Torres; Samantha Y A Terry; Peter Roselt; Rodney J Hicks; Philip J Blower
Journal:  Bioconjug Chem       Date:  2015-09-02       Impact factor: 4.774

View more
  7 in total

Review 1.  A review of advances in the last decade on targeted cancer therapy using 177Lu: focusing on 177Lu produced by the direct neutron activation route.

Authors:  Rubel Chakravarty; Sudipta Chakraborty
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-12-15

Review 2.  Advances in positron emission tomography tracers related to vascular calcification.

Authors:  Wenjun Yang; Zhiqi Zhong; Guoquan Feng; Zhongqun Wang
Journal:  Ann Nucl Med       Date:  2022-07-14       Impact factor: 2.258

3.  Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes.

Authors:  Giuseppe Floresta; Siham Memdouh; Truc Pham; Michelle T Ma; Philip J Blower; Robert C Hider; Vincenzo Abbate; Agostino Cilibrizzi
Journal:  Dalton Trans       Date:  2022-08-30       Impact factor: 4.569

Review 4.  Hydroxy- and Amino-Phosphonates and -Bisphosphonates: Synthetic Methods and Their Biological Applications.

Authors:  Babak Kaboudin; Payam Daliri; Samaneh Faghih; Hesam Esfandiari
Journal:  Front Chem       Date:  2022-06-01       Impact factor: 5.545

5.  NHS-Functionalized THP Derivative for Efficient Synthesis of Kit-Based Precursors for 68Ga Labeled PET Probes.

Authors:  Giuseppe Floresta; George P Keeling; Siham Memdouh; Levente K Meszaros; Rafael T M de Rosales; Vincenzo Abbate
Journal:  Biomedicines       Date:  2021-04-01

Review 6.  Cold Kit Labeling: The Future of 68Ga Radiopharmaceuticals?

Authors:  Nicolas Lepareur
Journal:  Front Med (Lausanne)       Date:  2022-02-10

7.  HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis.

Authors:  Juan Pellico; Irene Fernández-Barahona; Jesús Ruiz-Cabello; Lucía Gutiérrez; María Muñoz-Hernando; María J Sánchez-Guisado; Irati Aiestaran-Zelaia; Lydia Martínez-Parra; Ignacio Rodríguez; Jacob Bentzon; Fernando Herranz
Journal:  ACS Appl Mater Interfaces       Date:  2021-09-16       Impact factor: 9.229

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.